10+ can't-miss virtual business and innovation events in Houston for April

where to be online

Here's what interactive, virtual events to log on to this month. Katleho Seisa/Getty Images

Going into April, the city of Houston has another month at least of working from home, hopping on calls, and setting up video chats — but you don't have to go through this all alone.

Here are over 10 Houston innovation events you can attend virtually via online meetings. Be sure to register in advance, as most will send an access link ahead of the events.

April 1 — Social Entrepreneurship Meetup

Impact Hub Houston is bringing this monthly meetup online. Registrants will receive an email with the link to attend the Zoom meeting.


Details: The event is at 5:30 pm on Wednesday, April 1. Learn more.

April 2 — Considerations for Emerging Companies in the COVID-19 Era

A group of experts will discuss how the coronavirus and all its resulting complications will affect startups.

Details: The event is at 2 pm on Thursday, April 2. Learn more.

April 3 — UH's Red Labs Pitch Madness

You are invited to watch the final round of Pitch Madness, a pitch competition for UH students. Students will give a four minute pitch and be asked questions about their startup idea by judges. You can attend digitally the finals and watch students pitch at bit.ly/pitchmadness_finals.

Details: The event is at 1 pm on Friday, April 3. Learn more.

April 7 — CARES Act and Managing your Startup through the COVID Crisis

Carolyn Rodz, CEO of Alice, and Aziz Gilani, managing director of Mercury Fund, answer tech startups' questions about the CARES Act. Zoom link will be sent to attendee's prior to the event.

Details: The event is at 4 pm on Tuesday, April 7. Learn more.

April 8 — Startups & Sustainability - How to Make a Profit and Impact

Join as General Assembly brings together entrepreneurs in sustainability to examine how business and tech can be a force for good. Hear from leaders who will share their insights into how industry can impact the environment. Event will be hosted via Zoom, and registrants will be sent a link to attend.

Details: The event is at 5:45 pm on Wednesday, April 8. Learn more.

April 9 — Out of the Lab & Into the Newsroom: Media 101

This JLABs webinar will discuss trends in the media world, how these impact best outreach practices, and tips for designing a successful media campaign.

Details: The event is at 9 am on Thursday, April 9. Learn more.

April 9 — Webinar: In Today's Market - Do Patents Even Matter?

Inventors and business professionals are asked to review the claims of their patent application before it is filed. This step is THE critical step that is supposed to ensure that the claims will protect their invention. The decision you make here determines if you will be part of the 97% of all patents that never recoup the cost of filing them. This event is virtual and a Zoom link will be emailed on the day of the event.

Details: The event is at noon on Thursday, April 9. Learn more.

April 13-16 — Capital Factory's Founders Academy Essentials

Amongst all the excitement of running a startup is a lot of hard work and stressful decisions. Founders Academy Essentials is a 4-day lunch-n-learn curriculum designed specifically for driven entrepreneurs that are passionate about their business potential.

Details: The event is from Monday, April 13, to Thursday, April 16. Learn more.

April 14 — Black in Tech Summit

Capital Factory welcomes you to its 2nd Annual Black In Tech Summit. We're dedicated to increasing diversity in the tech community and making our coworking space an inclusive environment for people of all backgrounds and identities.

Details: The event is at noon on Tuesday, April 14. Learn more.

April 21 — Don’t Go Pitching in the Dark: How to Navigate Investor Interactions

In this webinar, experts of the craft will share practical tips on becoming more effective in communicating your story to investors, increasing your chances of successful fundraising.

Details: The event is at 9 am on Tuesday, April 21. Learn more.

April 21 — Employable in 2030: Closing the skills gap.

What jobs will exist in 2030? Come along and hear from a panel of industry leaders on how to stay relevant in the rapidly changing space for 2030 and beyond. Event will be hosted via Zoom, and registrants will be sent a link to attend.

Details: The event is at 7 pm on Tuesday, April 21. Learn more.

April 22 — Ion Startup Demo Day (Virtual Edition)

Top tier mentors, local investors, and personalized pitch feedback for participating startups -- nothing's changed but the address. Whether you're a serial entrepreneur or just looking to get involved in the community, this event is for YOU.

Details: The event is at 6 pm on Wednesday, April 22. Learn more.

------

For more virtual events, check out Houston Exponential's calendar.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

5 Houston scientists named winners of prestigious Hill Prizes 2026

prized research

Five Houston scientists were recognized for their "high-risk, high-reward ideas and innovations" by Lyda Hill Philanthropies and the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST).

The 2026 Hill Prizes provide seed funding to top Texas researchers. This year's prizes were given out in seven categories, including biological sciences, engineering, medicine, physical sciences, public health and technology, and the new artificial intelligence award.

Each recipient’s institution or organization will receive $500,000 in direct funding from Dallas-based Lyda Hill Philanthropies. The organization has also committed to giving at least $1 million in discretionary research funding on an ad hoc basis for highly-ranked applicants who were not selected as recipients.

“It is with great pride that I congratulate this year’s Hill Prizes recipients. Their pioneering spirit and unwavering dedication to innovation are addressing some of the most pressing challenges of our time – from climate resilience and energy sustainability to medical breakthroughs and the future of artificial intelligence,” Lyda Hill, founder of Lyda Hill Philanthropies, said in a news release.

The 2026 Houston-area recipients include:

Biological Sciences: Susan M. Rosenberg, Baylor College of Medicine

Rosenberg and her team are developing ways to fight antibiotic resistance. The team will use the funding to screen a 14,000-compound drug library to identify additional candidates, study their mechanisms and test their ability to boost antibiotic effectiveness in animal models. The goal is to move toward clinical trials, beginning with veterans suffering from recurrent infections.

Medicine: Dr. Raghu Kalluri, The University of Texas MD Anderson Cancer Center

Kalluri is developing eye drops to treat age-related macular degeneration (AMD), the leading cause of vision loss globally. Kalluri will use the funding to accelerate studies and support testing for additional ocular conditions. He was also named to the National Academy of Inventors’ newest class of fellows last month.

Engineering: Naomi J. Halas, Rice University

Co-recipeints: Peter J. A. Nordlander and Hossein Robatjazi, Rice University

Halas and her team are working to advance light-driven technologies for sustainable ammonia synthesis. The team says it will use the funding to improve light-driven catalysts for converting nitrogen into ammonia, refine prototype reactors for practical deployment and partner with industry collaborators to advance larger-scale applications. Halas and Nordlander are co-founders of Syzygy Plasmonics, and Robatjazi serves as vice president of research for the company.

The other Texas-based recipients include:

  • Artificial Intelligence: Kristen Grauman, The University of Texas at Austin
  • Physical Sciences: Karen L. Wooley, Texas A&M University; Co-Recipient: Matthew Stone, Teysha Technologies
  • Public Health: Dr. Elizabeth C. Matsui, The University of Texas at Austin and Baylor College of Medicine
  • Technology: Kurt W. Swogger, Molecular Rebar Design LLC; Co-recipients: Clive Bosnyak, Molecular Rebar Design, and August Krupp, MR Rubber Business and Molecular Rebar Design LLC

Recipients will be recognized Feb. 2 during the TAMEST 2026 Annual Conference in San Antonio. They were determined by a committee of TAMEST members and endorsed by a committee of Texas Nobel and Breakthrough Prize Laureates and approved by the TAMEST Board of Directors.

“On behalf of TAMEST, we are honored to celebrate the 2026 Hill Prizes recipients. These outstanding innovators exemplify the excellence and ambition of Texas science and research,” Ganesh Thakur, TAMEST president and a distinguished professor at the University of Houston, added in the release. “Thanks to the visionary support of Lyda Hill Philanthropies, the Hill Prizes not only recognize transformative work but provide the resources to move bold ideas from the lab to life-changing solutions. We are proud to support their journeys and spotlight Texas as a global hub for scientific leadership.”

Investment bank opens new Houston office focused on energy sector

Investment bank Cohen & Co. Capital Markets has opened a Houston office to serve as the hub of its energy advisory business and has tapped investment banking veteran Rahul Jasuja as the office’s leader.

Jasuja joined Cohen & Co. Capital Markets, a subsidiary of financial services company Cohen & Co., as managing director, and head of energy and energy transition investment banking. Cohen’s capital markets arm closed $44 billion worth of deals last year.

Jasuja previously worked at energy-focused Houston investment bank Mast Capital Advisors, where he was managing director of investment banking. Before Mast Capital, Jasuja was director of energy investment banking in the Houston office of Wells Fargo Securities.

“Meeting rising [energy] demand will require disciplined capital allocation across traditional energy, sustainable fuels, and firm, dispatchable solutions such as nuclear and geothermal,” Jasuja said in a news release. “Houston remains the center of gravity where capital, operating expertise, and execution come together to make that transition investable.”

The Houston office will focus on four energy verticals:

  • Energy systems such as nuclear and geothermal
  • Energy supply chains
  • Energy-transition fuel and technology
  • Traditional energy
“We are making a committed investment in Houston because we believe the infrastructure powering AI, defense, and energy transition — from nuclear to rare-earth technology — represents the next secular cycle of value creation,” Jerry Serowik, head of Cohen & Co. Capital Markets, added in the release.

---

This article originally appeared on EnergyCaptialHTX.com.

MD Anderson makes AI partnership to advance precision oncology

AI Oncology

Few experts will disagree that data-driven medicine is one of the most certain ways forward for our health. However, actually adopting it comes at a steep curve. But what if using the technology were democratized?

This is the question that SOPHiA GENETICS has been seeking to answer since 2011 with its universal AI platform, SOPHiA DDM. The cloud-native system analyzes and interprets complex health care data across technologies and institutions, allowing hospitals and clinicians to gain clinically actionable insights faster and at scale.

The University of Texas MD Anderson Cancer Center has just announced its official collaboration with SOPHiA GENETICS to accelerate breakthroughs in precision oncology. Together, they are developing a novel sequencing oncology test, as well as creating several programs targeted at the research and development of additional technology.

That technology will allow the hospital to develop new ways to chart the growth and changes of tumors in real time, pick the best clinical trials and medications for patients and make genomic testing more reliable. Shashikant Kulkarni, deputy division head for Molecular Pathology, and Dr. J. Bryan, assistant professor, will lead the collaboration on MD Anderson’s end.

“Cancer research has evolved rapidly, and we have more health data available than ever before. Our collaboration with SOPHiA GENETICS reflects how our lab is evolving and integrating advanced analytics and AI to better interpret complex molecular information,” Dr. Donna Hansel, division head of Pathology and Laboratory Medicine at MD Anderson, said in a press release. “This collaboration will expand our ability to translate high-dimensional data into insights that can meaningfully advance research and precision oncology.”

SOPHiA GENETICS is based in Switzerland and France, and has its U.S. offices in Boston.

“This collaboration with MD Anderson amplifies our shared ambition to push the boundaries of what is possible in cancer research,” Dr. Philippe Menu, chief product officer and chief medical officer at SOPHiA GENETICS, added in the release. “With SOPHiA DDM as a unifying analytical layer, we are enabling new discoveries, accelerating breakthroughs in precision oncology and, most importantly, enabling patients around the globe to benefit from these innovations by bringing leading technologies to all geographies quickly and at scale.”

View All Listings